(HealthDay)—Daily oral perampanel is generally well tolerated, with favorable retention rates among patients with epilepsy aged 1 to younger than 18 years, according to a study recently published in the Journal of Child Neurology.
Oral perampanel well tolerated in pediatric epilepsy
(HealthDay)—Daily oral perampanel is generally well tolerated, with favorable retention rates among patients with epilepsy aged 1 to younger than 18 years, according to a study recently published in the Journal of Child Neurology.